Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Wall thickness ≥ 15 mm in one or more myocardial segments that is not explained by loading conditions.~* LVOT gradient \> 30 mmHg at rest and/or \> 50 mmHg at Valsalva's maneuver or exercise~* New York Heart Association Functional class (NYHA) ≥ II~Exclusion Criteria:~* Age \< 18 years~* Known allergy to trial medicine~* Contraindications to beta-blocker treatment~* Contraindications to Magnetic resonans scan, including contraindication to the contrast agent gadolinium.~* Female patients who are pregnant (positive plasma-HCG), breastfeeding or of child-bearing potential while not practicing effective chemical contraceptive hormones.~* In case of patients having a pacemaker, they may not be pace-dependent.~* Treatment with Amiodarone~* Atrial fibrillation/flutter at the time of examination~* Bradycardia \< 49 beats/min~* Systolic blood pressure \< 100 mmHg~* Trifascicular block~* Previous transcoronary ablation of septum hypertrophy (TASH) or myectomy~* Current abuse of alcohol and/or drugs~* Significant co-morbidity or issues that makes the patient unsuitable for participation, judged by the investigator~* Patients who cannot give valid consent (e.g. mental illness or dementia)~* Patients who do not understand danish

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Metoprolol Succinate (Type: ACTIVE_COMPARATOR): Metoprololsuccinat
- Placebo oral capsule (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).